166 related articles for article (PubMed ID: 21842202)
1. Laryngeal carcinoma prognosis after postoperative radiotherapy correlates with CD105 expression, but not with angiogenin or EGFR expression.
Marioni G; Blandamura S; Loreggian L; Koussis H; Lionello M; Giacomelli L; Fasanaro E; Lovato A; Staffieri A
Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1779-87. PubMed ID: 21842202
[TBL] [Abstract][Full Text] [Related]
2. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival.
Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A
Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379
[TBL] [Abstract][Full Text] [Related]
3. Indications for postoperative radiotherapy in laryngeal carcinoma: a panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study.
Marioni G; Blandamura S; Lionello M; Giacomelli L; Lovato A; Favaretto N; Breda S; Tealdo G; Guzzardo V; Ottaviano G; Staffieri A
Head Neck; 2014 Nov; 36(11):1534-40. PubMed ID: 23996283
[TBL] [Abstract][Full Text] [Related]
4. CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma.
Zvrko E; Mikic A; Vuckovic L
Eur Arch Otorhinolaryngol; 2009 Dec; 266(12):1971-6. PubMed ID: 19340447
[TBL] [Abstract][Full Text] [Related]
5. The EGFR-mTOR pathway and laryngeal cancer angiogenesis.
Lionello M; Lovato A; Staffieri A; Blandamura S; Turato C; Giacomelli L; Staffieri C; Marioni G
Eur Arch Otorhinolaryngol; 2014 Apr; 271(4):757-64. PubMed ID: 24065188
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of hypoxia-inducible factors (angiogenin and endoglin) in open partial laryngectomies: uni- and multivariate analyses.
Marioni G; Staffieri A; Hagen R; Ottaviano G; Lionello M; Staffieri C; Giacomelli L; Blandamura S
Am J Otolaryngol; 2013; 34(1):3-9. PubMed ID: 22784587
[TBL] [Abstract][Full Text] [Related]
7. The role of angiogenin in pT1-T2 tongue carcinoma neo-angiogenesis and cell proliferation: an exploratory study.
Marioni G; Staffieri A; Fasanaro E; Stramare R; Giacomelli L; Bernardi E; Val M; Stellini E; de Filippis C; Blandamura S
J Oral Pathol Med; 2013 Sep; 42(8):606-11. PubMed ID: 23432607
[TBL] [Abstract][Full Text] [Related]
8. Neoangiogenesis in temporal bone carcinoma: the prognostic role of CD105.
Marioni G; Nucci R; Marino F; Giacomelli L; Rugge M; Pareschi R; Martini A
Otol Neurotol; 2012 Jul; 33(5):843-8. PubMed ID: 22643443
[TBL] [Abstract][Full Text] [Related]
9. Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2 (Flk-1/Kdr) expression.
Marioni G; Giacomelli L; D'Alessandro E; Staffieri C; Guzzardo V; Staffieri A; Blandamura S
Anticancer Res; 2008; 28(1B):551-7. PubMed ID: 18383901
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma.
Kontić M; Milovanović J; Čolović Z; Poljak NK; Šundov Ž; Sučić A; Pešutić-Pisac V
Eur Arch Otorhinolaryngol; 2015 Feb; 272(2):401-5. PubMed ID: 25294054
[TBL] [Abstract][Full Text] [Related]
12. A higher CD105-assessed microvessel density and worse prognosis in elderly patients with laryngeal carcinoma.
Marioni G; Staffieri A; Manzato E; Ralli G; Lionello M; Giacomelli L; Prosenikliev V; Marchese-Ragona R; Busnardo A; Bolzetta F; Blandamura S
Arch Otolaryngol Head Neck Surg; 2011 Feb; 137(2):175-80. PubMed ID: 21339405
[TBL] [Abstract][Full Text] [Related]
13. High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study.
Lionello M; Blandamura S; Loreggian L; Ottaviano G; Giacomelli L; Marchese-Ragona R; Velardita C; Staffieri A; Marioni G
J Oral Pathol Med; 2012 Feb; 41(2):136-40. PubMed ID: 21943204
[TBL] [Abstract][Full Text] [Related]
14. CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma.
Marioni G; D'Alessandro E; Giacomelli L; Staffieri A
J Oral Pathol Med; 2010 May; 39(5):361-7. PubMed ID: 20537053
[TBL] [Abstract][Full Text] [Related]
15. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma.
Marioni G; Ottaviano G; Giacomelli L; Staffieri C; Casarotti-Todeschini S; Bonandini E; Staffieri A; Blandamura S
Eur J Surg Oncol; 2006 Dec; 32(10):1149-53. PubMed ID: 16979866
[TBL] [Abstract][Full Text] [Related]
16. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.
Lionello M; Blandamura S; Staffieri C; Tealdo G; Giacomelli L; Marchese Ragona R; de Filippis C; Staffieri A; Marioni G
Am J Otolaryngol; 2015; 36(2):184-9. PubMed ID: 25459315
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin expression and laryngeal squamous cell carcinoma prognosis: novel preliminary evidence.
Marioni G; Staffieri A; Giacomelli L; Lionello M; Guzzardo V; Busnardo A; Blandamura S
Histopathology; 2011 Jun; 58(7):1148-56. PubMed ID: 21707714
[TBL] [Abstract][Full Text] [Related]
19. A panel of biomarkers for predicting response to postoperative RT for laryngeal cancer?
Marioni G; Ottaviano G; Lionello M; Fasanaro E; Staffieri C; Giacomelli L; Gattazzo S; Staffieri A; Blandamura S
Am J Otolaryngol; 2014; 35(6):771-8. PubMed ID: 25064017
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.
Nijkamp MM; Span PN; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende PL; de Jong M; van der Kogel AJ; Bussink J; Kaanders JH
Eur J Cancer; 2013 Oct; 49(15):3202-9. PubMed ID: 23867129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]